argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$941.25−6.27 (-0.66%)
Close on Nov 18, 2026Market cap –P/E 48.1Yield –
argenx pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
argenx's pe ratio was 50.0× on Nov 11, 2026, against 71.4× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 50.0× | −15.8 |
| 2025 | Dec 31, 2025 | 65.8× | – |
See a number that looks wrong?